- Hepatic impairment
- Known/suspected urea cycle disorders (may result in fatal hyperammonemic encephalopathy).
Use Cautiously in:
- All patients (may ↑ risk of suicidal thoughts/behaviors)
- Bleeding disorders
- History of liver disease
- Organic brain disease
- Bone marrow depression
- Renal impairment
- Women of childbearing potential
- Geri: ↑ risk of adverse effects
- OB: Use during pregnancy is linked to congenital anomalies, neural tube defects, clotting abnormalities, and hepatic dysfunction in the neonate as well as impaired cognitive development as the child matures. Use with extreme caution. Lactation: Pass into breast milk. Consider discontinuing nursing when valproates are administered to the nursing mother
- Pedi: Children, especially <2 yr (at ↑ risk for potentially fatal hepatotoxicity).
VALPROATES has been found in Davis's Drug Guide
If you are a registered user, please login below.
If not, learn more about gaining full access.
- Try and Buy
- Nursing Central puts five fully integrated references at your fingertips on mobile devices and the web. See how Nursing Central works by clicking the sample entries below or purchase a subscription for the web and your mobile device.
View these free topics online now.